Market Research Insights

San Francisco, 29 July 2019:   The Report   Amyloidosis Treatment Market   Size, Share & Trends Analysis Report By Treatment (Stem Cell Transplant, Chemotherapy, Supportive Care, Surgery, Targeted Therapy), By Country, And Segment Forecasts, 2018 – 2025 The global amyloidosis treatment market size is expected to reach USD 6.7 billion by 2025, according to a new report by Grand View Research, Inc., registering a 7.2% CAGR during the forecast period. Several factors such as increased adoption of novel targeted therapies and transplantations, emergence of biologics, and rising geriatric population are driving the market. Amyloidosis is a group of rare diseases where misfolded aggregates of proteins (amyloids) buildup in tissues and organs. AL amyloidosis is the most common type of amyloidosis in U.S., with approximately 3,000 to 4,000 new cases diagnosed annually. Although in majority of cases, the disease is diagnosed in people over the age of 60, there are a few cases of people

San Francisco, 29 July 2019:   The Report   Regenerative Medicine Market   Size, Share & Trends Analysis By Product (Primary Cell-based, Stem & Progenitor Cell-based), By Therapeutic Category (Dermatology, Oncology) And Segment Forecasts, 2019 – 2025 The global regenerative medicine market size is expected to reach USD 5.60 billion by 2025, expanding at a CAGR of 11.6% over the forecast period, according to a new report by Grand View Research, Inc. Regenerative medicines are expected to have a significant impact in healthcare to treat specific indications and chronic conditions. Therefore, high prevalence of cancer, neurodegenerative, orthopedic, and other aging-associated disorders coupled with increasing global geriatric population is driving the market growth. Moreover, rising prevalence of inheritable genetic diseases is anticipated to fuel the demand in the field of biotechnology field. Market players are engaged in implementing novel protocols for the release of nove

San Francisco, 29 July 2019:   The Report   Vitamin D Testing Market   Analysis By Type of Test (25-Hydroxy Vitamin D Tests; 1, 25-Dihydroxy Vitamin D Tests), Region (North America, Europe, Asia Pacific, South & Central America, MEA), And Segment Forecasts, 2018 – 2025 The global vitamin D testing market is expected to reach USD 1.1 billion by 2025, according to a new report by Grand View Research, Inc. Global increase in geriatric population as well as cases of chronic illnesses is likely to drive the market during the forecast period. Furthermore, increase in investment for development and commercialization of various accurate, innovative, and easy-to-use tests by various market players and governments is likely to drive the market growth. For instance, in January 2017, Future Diagnostics and DIA source received a grant of EUR 1.4 million from the European Commission to develop a unique CE-marked assay that can measure the level of free vitamin D (25OHD) in the body. In addi

San Francisco, 29 July 2019:  The Report   Implantable Drug Delivery Devices Market   Analysis Report By Type (Biodegradable, Non-biodegradable), By Product, By Technology (Diffusion, Osmotic, Magnetic), By Application, And Segment Forecasts, 2018 – 2025 The global implantable drug delivery devices market size is expected to reach USD 31.6 billion by 2025, according to a new report by Grand View Research, Inc., registering a 7.5% CAGR during the forecast period. Growing incidence of chronic diseases, coupled with rising demand for minimally invasive treatment options, is driving the market for implantable drug delivery devices. Recent advancements in medication administration technologies are expected to fuel market growth over the forecast period. Increase in adoption of micro-scale implantable devices is one of the key factors fueling growth. These products find application in monitoring improvement in body functions, imaging, and medication administration. They facilitate local

San Francisco, 29 July 2019:   The Report   Protein Engineering Market   Analysis By Technology (Rational Protein Design, Directed Evolution, Hybrid Approach), By Protein Type (Insulin, Monoclonal Antibodies), By Product, By End-use, And Segment Forecasts, 2018 – 2025 The global protein engineering market is expected to reach USD 3.09 billion by 2025, according to a new report by Grand View Research, Inc. The market is driven by presence of regulatory authorities consistently striving to reduce time and cost involved in the drug discovery process. One such example is the launch of critical path initiative by U.S. FDA, for incorporation of advanced technologies, such as protein engineering, in drug discovery processes. Moreover, this facilitates prediction of probable adverse reactions & toxicity and improves efficacy of target molecules early on, resulting in lowered drug attrition rates in the later stages. This is anticipated to help control overall expenditure. Rise in R&

San Francisco, 29 July 2019:   The Report   Nephrology and Urology Devices Market   Analysis Report By Type (Dialysis, Benign Prostatic Hyperplasia, Endoscopy, Urinary Stone, Urinary Incontinence & Pelvic Organ Prolapse), And Segment Forecasts, 2018 – 2024 The global nephrology and urology devices market size is expected to reach USD 31.3 billion by 2024, according to a new report by Grand View Research, Inc., exhibiting a 7.1% CAGR during the forecast period. Increasing prevalence of chronic kidney diseases is expected to fuel market growth. This high prevalence of diseases can be attributed to unhealthy lifestyle habits of people around the world. Moreover, growing geriatric population, who are more prone to hypertension, obesity, diabetes, urinary disorders, and other kidney chronic conditions, is expected to fuel demand for nephrology and urology devices. Advancements in device technology, such as inclusion of prosthetics in urology, percutaneous methods for stone disinte

San Francisco, 26 July 2019:   The Report   3D Bioprinting Market  Size, Share & Trends Analysis Report By Technology (Magnetic Levitation, Inkjet-based, Syringe-based, Laser-based), By Application (Medical, Dental, Biosensors, Bioinks), And Segment Forecasts, 2019 – 2026 The global 3D bioprinting market size is expected to reach USD 4.1 billion by 2026 registering a CAGR of 19.5%, according to a new report by Grand View Research, Inc. Growing usage of 3D printing in cosmetic surgeries and innovations in the 3D bioprinting are expected to propel the market growth over the forecast period. The technology is commonly used to print prosthetics and dental accessories, medical devices, and bone implants. The medical application segment is projected to expand at a significant pace, as the technology has the potential to reduce the drug development costs. For instance, in March 2016, a U.S.-based specialty pharmaceutical firm became the world’s first company to receive approval from